Fimasartan Potassium Trihydrate
Tier C — Watch / tradeFimasartan Potassium Trihydrate
Targets：AT1
Brand：Arakhor, Kanarb
Indications (approved)：Hypertension, Essential hypertension
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| FIMA-001 | 1115-30-6 | diethyl 2-acetylsuccinate |
| FIMA-002 | 109-51-3 | pentanimidamide |
| FIMA-003 | 503155-65-5 | ethyl 2-(2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetate |
| FIMA-004 | 124750-51-2 | 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
| FIMA-005 | 503155-66-6 | ethyl 2-(2-butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)acetate |
| FIMA-006 | 1361024-33-0 | ethyl 2-(2-butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)acetate |
| FIMA-007 | 503155-67-7 | 2-(2-butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)-N,N-dimethylacetamide |
| FIMA-008 | 1361024-52-3 | 2-(2-butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)acetic acid |
| Code | CAS No. | Intermediate |
|---|---|---|
| FIMA-004 | 124750-51-2 | 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
| FIMA-007 | 503155-67-7 | 2-(2-butyl-4-methyl-6-oxo-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)-N,N-dimethylacetamide |
| FIMA-009 | 105-45-3Available | methyl 3-oxobutanoate |
| FIMA-010 | 2675-89-0 | 2-chloro-N,N-dimethylacetamide |
| FIMA-011 | 1315478-14-8 | methyl 2-acetyl-4-(dimethylamino)-4-oxobutanoate |
| FIMA-012 | 18257-46-0 | pentanimidamide;hydrochloride |
| FIMA-013 | - | methyl 2-acetyl-4-(dimethylamino)-4-oxobutanoate |
| Code | CAS No. | Intermediate |
|---|---|---|
| FIMA-004 | 124750-51-2 | 5-(4'-(bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
| FIMA-014 | 114772-53-1 | 4'-methyl-[1,1'-biphenyl]-2-carbonitrile |
| FIMA-015 | 120568-11-8 | 5-(4'-methyl-[1,1'-biphenyl]-2-yl)-1H-tetrazole |
| FIMA-016 | 124750-53-4 | 5-(4'-methyl-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole |
Frequently asked questions
What are the approved indications of Fimasartan Potassium Trihydrate?
Approved indications include: Hypertension, Essential hypertension.
When does the Fimasartan Potassium Trihydrate patent expire?
No public expiry year is available for Fimasartan Potassium Trihydrate yet; this page updates once verified.
How many synthesis routes are recorded for Fimasartan Potassium Trihydrate?
3 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Fimasartan Potassium Trihydrate intermediates?
1 intermediate CAS of Fimasartan Potassium Trihydrate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Fimasartan Potassium Trihydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29